213 related articles for article (PubMed ID: 30835490)
1. Electrophysiological and Pharmacological Characterization of Human Inwardly Rectifying K
Sanson C; Schombert B; Filoche-Rommé B; Partiseti M; Bohme GA
Assay Drug Dev Technol; 2019 Apr; 17(3):89-99. PubMed ID: 30835490
[TBL] [Abstract][Full Text] [Related]
2. PA-6 inhibits inward rectifier currents carried by V93I and D172N gain-of-function K
Ji Y; Veldhuis MG; Zandvoort J; Romunde FL; Houtman MJC; Duran K; van Haaften G; Zangerl-Plessl EM; Takanari H; Stary-Weinzinger A; van der Heyden MAG
J Biomed Sci; 2017 Jul; 24(1):44. PubMed ID: 28711067
[TBL] [Abstract][Full Text] [Related]
3. Efficient and specific cardiac IK₁ inhibition by a new pentamidine analogue.
Takanari H; Nalos L; Stary-Weinzinger A; de Git KC; Varkevisser R; Linder T; Houtman MJ; Peschar M; de Boer TP; Tidwell RR; Rook MB; Vos MA; van der Heyden MA
Cardiovasc Res; 2013 Jul; 99(1):203-14. PubMed ID: 23625347
[TBL] [Abstract][Full Text] [Related]
4. Role of plasma membrane-associated AKAPs for the regulation of cardiac I
Seyler C; Scherer D; Köpple C; Kulzer M; Korkmaz S; Xynogalos P; Thomas D; Kaya Z; Scholz E; Backs J; Karle C; Katus HA; Zitron E
Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):493-503. PubMed ID: 28331977
[TBL] [Abstract][Full Text] [Related]
5. Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore.
Amorós I; Dolz-Gaitón P; Gómez R; Matamoros M; Barana A; de la Fuente MG; Núñez M; Pérez-Hernández M; Moraleda I; Gálvez E; Iriepa I; Tamargo J; Caballero R; Delpón E
Biochem Pharmacol; 2013 Jul; 86(2):267-78. PubMed ID: 23648307
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP
Scherer D; Schworm B; Seyler C; Xynogalos P; Scholz EP; Thomas D; Katus HA; Zitron E
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jul; 390(7):701-710. PubMed ID: 28365825
[TBL] [Abstract][Full Text] [Related]
7. The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat.
Zhai XW; Zhang L; Guo YF; Yang Y; Wang DM; Zhang Y; Li P; Niu YF; Feng QL; Wu BW; Cao JM; Liu QH
PLoS One; 2017; 12(5):e0177600. PubMed ID: 28542320
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin Causes a Novel Proarrhythmic Syndrome.
Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents.
Gómez R; Caballero R; Barana A; Amorós I; De Palm SH; Matamoros M; Núñez M; Pérez-Hernández M; Iriepa I; Tamargo J; Delpón E
Cardiovasc Res; 2014 Nov; 104(2):337-46. PubMed ID: 25205296
[TBL] [Abstract][Full Text] [Related]
10. Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224.
Xynogalos P; Seyler C; Scherer D; Koepple C; Scholz EP; Thomas D; Katus HA; Zitron E
Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1153-61. PubMed ID: 25182566
[TBL] [Abstract][Full Text] [Related]
11. Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome.
El Harchi A; McPate MJ; Zhang Yh; Zhang H; Hancox JC
J Mol Cell Cardiol; 2009 Nov; 47(5):743-7. PubMed ID: 19285083
[TBL] [Abstract][Full Text] [Related]
12. Kir2.1 and K2P1 channels reconstitute two levels of resting membrane potential in cardiomyocytes.
Zuo D; Chen K; Zhou M; Liu Z; Chen H
J Physiol; 2017 Aug; 595(15):5129-5142. PubMed ID: 28543529
[TBL] [Abstract][Full Text] [Related]
13. Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.
Pérez-Hernández M; Matamoros M; Alfayate S; Nieto-Marín P; Utrilla RG; Tinaquero D; de Andrés R; Crespo T; Ponce-Balbuena D; Willis BC; Jiménez-Vazquez EN; Guerrero-Serna G; da Rocha AM; Campbell K; Herron TJ; Díez-Guerra FJ; Tamargo J; Jalife J; Caballero R; Delpón E
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232268
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1.
Kiesecker C; Zitron E; Scherer D; Lueck S; Bloehs R; Scholz EP; Pirot M; Kathöfer S; Thomas D; Kreye VA; Kiehn J; Borst MM; Katus HA; Schoels W; Karle CA
J Mol Med (Berl); 2006 Jan; 84(1):46-56. PubMed ID: 16258766
[TBL] [Abstract][Full Text] [Related]
15. Regional variation of the inwardly rectifying potassium current in the canine heart and the contributions to differences in action potential repolarization.
Cordeiro JM; Zeina T; Goodrow R; Kaplan AD; Thomas LM; Nesterenko VV; Treat JA; Hawel L; Byus C; Bett GC; Rasmusson RL; Panama BK
J Mol Cell Cardiol; 2015 Jul; 84():52-60. PubMed ID: 25889894
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2.
Scherer D; Seyler C; Xynogalos P; Scholz EP; Thomas D; Backs J; Andrassy M; Völkers M; Karle CA; Katus HA; Zitron E
PLoS One; 2016; 11(5):e0156181. PubMed ID: 27214373
[TBL] [Abstract][Full Text] [Related]
17. Expression of the inwardly rectifying K+ channel Kir2.1 in native bovine corneal endothelial cells.
Yang D; MacCallum DK; Ernst SA; Hughes BA
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3511-9. PubMed ID: 12882801
[TBL] [Abstract][Full Text] [Related]
18. Functional expression of a Kir2.1-like inwardly rectifying potassium channel in mouse mammary secretory cells.
Kamikawa A; Ishikawa T
Am J Physiol Cell Physiol; 2014 Feb; 306(3):C230-40. PubMed ID: 24259419
[TBL] [Abstract][Full Text] [Related]
19. A High-Throughput Electrophysiology Assay Identifies Inhibitors of the Inwardly Rectifying Potassium Channel Kir7.1.
Wright PD; Kanumilli S; Tickle D; Cartland J; Bouloc N; Dale T; Tresize DJ; McCloskey C; McCavera S; Blanks AM; Kettleborough C; Jerman JC
J Biomol Screen; 2015 Jul; 20(6):739-47. PubMed ID: 25656238
[TBL] [Abstract][Full Text] [Related]
20. Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept.
Thomet U; Amuzescu B; Knott T; Mann SA; Mubagwa K; Radu BM
Eur J Pharmacol; 2021 Dec; 913():174632. PubMed ID: 34785211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
